Reshape Biotech

Reshape Biotech

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Reshape Biotech, founded in 2019 and based in Copenhagen, is a technology company focused on automating and digitizing laboratory workflows. Its core offering is an integrated ecosystem of robotic hardware (smart incubators, high-throughput imagers) and a cloud software platform that uses AI to automatically image and analyze plate-based microbiological assays. The platform targets R&D and quality control labs, aiming to reduce manual work, minimize errors, and generate standardized, searchable data to accelerate research. Customer testimonials highlight significant reductions in false negatives and massive increases in screening throughput.

AI / Machine LearningDigital HealthDrug Delivery

Technology Platform

Integrated ecosystem of robotic lab hardware (smart incubators, high-throughput imagers) and a cloud-based AI software platform (Discovery Platform) that automates imaging and analysis of plate-based microbiological assays.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The global drive for lab automation, AI integration, and data reproducibility in life sciences creates a large and growing market.
The platform's ability to generate standardized, AI-ready data from routine assays positions it as a critical infrastructure for data-driven R&D.
Expansion into adjacent verticals like industrial biotech QC and regulated testing offers further growth avenues.

Risk Factors

Key risks include technological execution, particularly the reliability and breadth of its AI analysis models.
The company faces competition from established lab automation vendors and must navigate long sales cycles to displace existing lab workflows.
As a private, capital-intensive hardware-software business, it also faces financial risks associated with scaling and fundraising.

Competitive Landscape

Reshape operates in the competitive lab automation and AI-for-science space. It competes with large instrument manufacturers (e.g., Thermo Fisher, Agilent, PerkinElmer) offering robotic systems, and with software-focused startups providing AI image analysis for life sciences. Its differentiated integrated hardware-software platform and focus on microbiological assays provide a niche, but it must continually innovate against both broad and specialized competitors.